2024 Speaker Faculty

Thank you to our speakers, sponsors, and delegates who joined us in June for the summit! If you are interested in the 2025 event, please get in touch at info@hansonwade.com

Alison LaPidus, Cell & Gene Therapy Pricing & Reimbursement

Alison Lapidus

Director Value-Driven Healthcare Unit

PhRMA

Amar Kelkar - Cell and Gene Therapy Pricing and Reimbursement Summit

Amar Kelkar

Stem Cell Transplantation Physician

Dana-Farber Cancer Institute

Cole Boskey, Cell & Gene Therapy Pricing & Reimbursement

Cole Boskey

Head of Commercial

CCX

David Foell, Cell & Gene Therapy Pricing & Reimbursement

David Foell

Senior Director, Specialty Channel Operations

Ultragenyx Pharmaceutical Inc

Erica Cischke - Cell and Gene Therapy Pricing and Reimbursement Summit

Erica Cischke

Vice President of Government Affairs

Alliance for Regenerative Medicine

Jeff Chaffin - Cell and Gene Therapy Pricing and Reimbursement Summit

Jeff Chaffin

Market Access Strategy Leader

Independent Expert

Jesse Lemberger - Cell and Gene Therapy Pricing and Reimbursement Summit

Jesse Lemberger

Senior Director US Strategic Pricing

Pfizer

Jie Zhang - Cell and Gene Therapy Pricing and Reimbursement Summit

Jie Zhang

Global Value & Access

Cell & Gene Independent Expert

Kristin Wolff - Cell and Gene Therapy Pricing and Reimbursement Summit

Kristin Wolff

Vice President, Market Access

bluebird bio

Kyle Clifton, Cell & Gene Therapy Pricing & Reimbursement

Kyle Clifton

Senior Director, Market Access & Commercialization Services

Red Nucleus

Laura Okpala - Cell and Gene Therapy Pricing and Reimbursement Summit

Laura Okpala

Executive Director, Head of Reimbursement Policy, Government Affairs

Gilead Sciences

Manpreet Sidhu - Cell and Gene Therapy Pricing and Reimbursement Summit

Manpreet Sidhu

Executive Director - Global Health Economics, Outcomes Research & Epidemiology

Ultragenyx

Marianne Hamilton Lopez - Cell and Gene Therapy Pricing and Reimbursement Summit

Marianne Hamilton Lopez

Senior Research Director

Duke-Margolis Center for Health Policy

Mark Trusheim - Cell and Gene Therapy Pricing and Reimbursement Summit

Mark Trusheim

Strategic Director

NEWDIGS, Tufts Medical Center

Matthew Feshbach - Cell and Gene Therapy Pricing and Reimbursement Summit

Matt Feshbach

Founder & Chief Executive Officer

AMBROSE Cell Therapy

Phung Osborn - Cell & Gene Therapy Pricing & Reimbursement

Phung Osborn

Vice President - Market Access

Orca Bio

Sean Dickson, Cell & Gene Therapy Pricing & Reimbursement

Sean Dickson

Vice President

America's Health Insurance Plans - AHIP

Sumeet Panjabi - Cell and Gene Therapy Pricing and Reimbursement Summit

Sumeet Panjabi

Senior Director, Real World Value & Evidence

Johnson & Johnson Services, Inc

Terry Cothran

Senior Pharmacy Director

Oklahoma Health Care Authority

Tom Dever, Cell & Gene Therapy Pricing & Reimbursement

Tom Dever

Global & U.S. Pharmaceutical Market Access & Pricing/Commercialization

Independent Expert

Tom Smith, Cell & Gene Therapy Pricing & Reimbursement

Tom Smith

Strategic Initiatives Director

Uniphar

FULL EVENT GUIDE
REGISTER INTEREST
PARTNER